Non-Hodgkin Lymphoma
RareCancer
Non-Hodgkin Lymphoma is treated with 5 medications in our database, including Cyclophosphamide, IMULDOSA, Plerixafor, Truxima, Riabni. 3 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Baxter, Accord BioPharma, Sanofi, Celltrion, Amgen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Non-Hodgkin Lymphoma treatment below.
What help exists for Non-Hodgkin Lymphoma
15
drugs indexed
10
with copay cards
10
with patient assistance
2
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Non-Hodgkin Lymphoma
15 totalJYLAMVO
Methotrexate Β· Nexus
ππBendamustine
BENDAMUSTINE HYDROCHLORIDE Β· Teva
ππRiabni
rituximab-arrx Β· Amgen
ππBendeka
bendamustine hydrochloride Β· Eagle
METHOTREXATE
Methotrexate
PLERIXAFOR
plerixafor Β· Sanofi
ππCyclophosphamide
Cyclophosphamide Β· Baxter
IMULDOSA
ustekinumab-srlf Β· Accord BioPharma
ππVIVIMUSTA
BENDAMUSTINE HYDROCHLORIDE Β· Slayback Pharma LLC
ππMethotrexate Sodium
Methotrexate Sodium Β· Pfizer
TREANDA
Bendamustine Hydrochloride Β· Teva
ππTruxima
rituximab-abbs Β· Celltrion
Xatmep
Methotrexate
ππBELRAPZO
bendamustine hydrochloride Β· Eagle
ππBendamustine Hydrochloride
BENDAMUSTINE HYDROCHLORIDE Β· Teva
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Non-Hodgkin Lymphoma drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 20 PA rules for Non-Hodgkin Lymphoma drugs. View individual drug pages for complete PA detail.
Grants for Non-Hodgkin Lymphoma patients
9 total Β· 2 open- open
Amgen Assist 360
Amgen
Covers: financial assistance
- open
Amgen SupportPlus Patient Support Program
Amgen
- unknown
Amgen Support Plus
Amgen
- unknown
Amgen Assist 360
Amgen
Covers: financial assistance
- unknown
Amgen Support Plus
Amgen
- unknown
Sanofi Patient Assistance Program
Sanofi
Covers: financial assistance
- unknown
AMGEN Assist
Amgen
Covers: financial assistance
- unknown
Sanofi Patient Connection
Sanofi
- unknown
Amgen Patient Assistance Program
Amgen
Covers: financial assistance
Non-Hodgkin Lymphoma is a rare disease β more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare β